(Q48676649)

14 February 2018

title

A comparison of the SF-36 and Nottingham Health Profile in patients with chronic neuropathic pain. (English)

1 reference

14 February 2018

0 references

0 references

0 references

chronic neuropathic pain

0 references

author name string

Meyer-Rosberg K

1

1 reference

14 February 2018

Burckhardt CS

2

1 reference

14 February 2018

Huizar K

3

1 reference

14 February 2018

Kvarnström A

4

1 reference

14 February 2018

Nordfors LO

5

1 reference

14 February 2018

Kristofferson A

6

1 reference

14 February 2018

publication date

1 January 2001

1 reference

14 February 2018

published in

European Journal of Pain

1 reference

14 February 2018

volume

5

1 reference

14 February 2018

page(s)

391-403

1 reference

14 February 2018

issue

4

1 reference

14 February 2018

Responsiveness of the SF-36 among veterans with diabetes mellitus

cites work

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Reliability of the Spanish version of the Nottingham Health Profile in patients with stable end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Diabetic peripheral neuropathy and quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Postherpetic neuralgia: role of gabapentin and other treatment modalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Differential item functioning in the Danish translation of the SF-36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Selection of quality-of-life measures for a prevention trial: a psychometric analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Neurogenic pain syndromes and their management

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Quality of life after adjuvant chemotherapy for breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

SF-36 health survey: tests of data quality, scaling assumptions, and reliability in a community sample of Chinese Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

A comparative review of generic quality-of-life instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

A community survey of diabetes in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Electronic quality of life questionnaires: a comparison of pen-based electronic questionnaires with conventional paper in a gastrointestinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

NHP or SIP--a comparative study in renal insufficiency associated anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

An empirical comparison of four generic health status measures. The Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Breast cancer survivors: psychosocial concerns and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Percutaneous electrical nerve stimulation: a novel analgesic therapy for diabetic neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Pain syndromes and etiologies in ambulatory AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Measurement of health status. Ascertaining the minimal clinically important difference

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Neuropathic pain in cancer and AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions and score reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Post-sympathectomy neuralgia: hypotheses on peripheral and central neuronal mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Chronic neuropathic pain and its control by drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

A systematic review of antidepressants in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Do we know what global ratings of health-related quality of life measure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

The Swedish SF-36 Health Survey II. Evaluation of clinical validity: results from population studies of elderly and women in Gothenborg.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

The Swedish SF-36 Health Survey--I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Reliability, validity, and application of the medical outcomes study 36-item short-form health survey (SF-36) in schizophrenic patients treated with olanzapine versus haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

A Kiswahili version of the SF-36 Health Survey for use in Tanzania: translation and tests of scaling assumptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Pain after breast surgery: a survey of 282 women

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

Interpretation of change scores in ordinal clinical scales and health status measures: The whole may not equal the sum of the parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FEUJP.2001.0260

21 January 2018

Identifiers

DOI

10.1053/EUJP.2001.0260

1 reference

14 February 2018

PubMed ID

11743705

1 reference

14 February 2018